<DOC>
	<DOCNO>NCT02284074</DOCNO>
	<brief_summary>The purpose study develop nasal challenge model cause mild degree inflammation , without cause pain symptom , allow u measure variety proteins nasal secretion cause inflammation nose . The nasal challenge model involve spray nostril form fine mist 4 different dos ( 1 , 10 , 30 100µg per nostril ) lipopolysaccharide ( LPS ) include placebo . LPS type protein carefully purify outer cell wall certain bacteria , sterile contain live bacteria , cause infection . The investigator measure inflammation nose look cell collect wash inside nose ( nasal lavage ) place small strip paper nasal cavity . The paper absorb nasal fluid chemical produce inflammation extract paper analyse laboratory . The investigator also collect small amount nasal epithelium take way nasal scrape ; do use Rhinoprobe , small plastic curette use scrape small piece line nose . The investigator hope information obtain study use future study test new study drug design treat disease airways lung ( like asthma chronic obstructive pulmonary disease ( COPD ) hay fever .</brief_summary>
	<brief_title>Nasal LPS Challenge Healthy Volunteers</brief_title>
	<detailed_description>STUDY DESIGN AND METHODOLOGY This single-centre study carry Imperial Clinical Respiratory Research Unit ( ICRRU ) St Mary 's Hospital London Paddington . RECRUITMENT The study recruit total 15 healthy participant . STUDY VISITS The study involve total 11 outpatient visit . The screen visit initial visit study discuss participant write informed consent obtain PI designee . This do prior perform study related procedure . The participant study information sheet least 24 hour prior visit . The visit include collection demographic data , height weight , physical examination doctor , medical history , vital sign , body temperature , 12 lead ECG , laboratory assessment ( safety blood ) urine drug abuse test pregnancy test female . The participant also ask indicate presence nasal symptom complete modified total nasal symptom score sheet perform peak nasal inspiratory flow ( PNIF ) test . If eligible , participant ask return study visit . Participants give 4 different dos LPS placebo randomise manner . There total 5 treatment period . Each treatment period consist 11h visit first day 20 minute visit follow day . There total 12-28 day interval treatment period visit . During treatment period visit , study participant undergo follow study procedure : 1 . Nasal lavage nostril discard 5ml 0.9 % saline order clean nose prior nasal LPS challenge . 2 . Nasal challenge LPS ( placebo , 1,10 , 30 100µg per nostril ) 3 . Nasosorption ( right nostril ) -30m , +30m , +1h , hourly 10h 24h 4 . Nasal lavage ( left nostril ) -30m , +2h , +4h , +8h , +24h 5 . Nasal scrape ( left nostril ) -30m , +3h , +6h , +24h 6 . Modified total nasal symptom score ( TNSS ) -30m , +30m , +1h , hourly 10h 24h 7 . Peak nasal inspiratory flow ( PNIF ) rate -30m , +2h , +4h , +8h , 24h 8 . Systemic adverse event 9 . Temperature ( oral ) -30m , +2h , +4h , +8h 10 . Blood pressure heart rate -30m 11 . Females child bear potential pregnancy test perform . NASAL PROCEDURES IN THE STUDY 1 . Nasal wash ( nasal lavage ) : Nasal washing nose carry pass small volume salt water ( saline ) fluid nose . A nasal adapter shape like olive place inside nostril . The participant ask sit forward salty water solution ( saline ) use flush nose one minute period . This procedure carry nostrils clean nose initial study visit repeat left nostril treatment visit . 2 . Nasal line fluid absorption ( nasosorption SAM ) : A small strip absorbent material , look feel like soft tissue paper , use absorb moisture inside surface nostril . The special absorptive paper place inside nostril leave period 2 minute absorb nasal line fluid remove , gently suck fluid like blot paper . Putting paper nose tickle , cause eye water little . However , nasosorption hurt investigator method prove well tolerated baby , child adult . The paper absorb nasal fluid many substance produce nasal cell extract paper measure laboratory . 3 . Nasal scrape ( nasal curettage Rhinoprobe ) : A small sterile disposable plastic probe insert nose gently press inside surface line nostril . The 3 inch long probe tiny scoop end , barely see . 24 tiny sample nostril ( pinhead , 2mm , tissue ) take part nose reduce nerve supply limit discomfort . Taking sample cause bleeding , may cause mild discomfort , may make eye water slightly . The probe collect nasal cell surface nostril sent analysis . This method perform many adult , child , baby , well tolerate . STATISTICAL ANALYSIS Each measure summarise descriptively dose time use appropriate summary statistic . If appropriate , response variable transform ( e.g . log-transformed ) . Gene expression data normalise house-keeper gene . The TNSS calculate sum score nasal blockage , nasal discharge/rhinorrhoea , nasal burning/itching/pain sensation , sneeze timepoint . Weighted mean symptom score calculate time interval 0 10h . TNSS , nasal sniff pressure , nasosorption measure gene expression data nasal scrape plot time , separate plot subject measure , LPS dose placebo represent separate line plot . Summary statistic ( e.g . mean +/- 95 % confidence interval median interquartile range ) nasal lavage gene expression data plot dose time . Correlations explore use scatter plot follow measure : - Weighted mean TNSS vs. maximum TNF-α - Weighted mean TNSS vs. maximum IL-8 - Weighted mean TNSS vs. maximum s-ICAM-1 - Maximum ICAM-1 expression vs. maximum TNF-α Reproducibility nasal LPS challenge ICAM-1 expression TNF-α explore use follow subset data : - Predose data period explore intra-subject variability . Parameter vs. period number plot separate line subject explore whether period effect . Box whisker plot also use summarise parameter period . - Placebo period data - Parameter v time plot separate line subject explore whether time-course effect . Box whisker plot also use summarise parameter time . Box whisker plot ICAM-1 expression TNF-α dose time present investigate whether measure return baseline 24h . Additional exploratory analysis may perform characterize expression profile ICAM follow nasal LPS challenge .</detailed_description>
	<criteria>INCLUSION CRITERIA Males female age 18 60 year Current nonsmoker last 6 month ( &lt; 5 cigs per week ) , smoke history &lt; 5 pack year BMI 2030 kg/m2 EXCLUSION CRITERIA History allergy Upper airway infection 2 week screen Lower respiratory tract infection past 3 month Treatment local systemic corticosteroid previous 2 month Signs symptom chronic rhinitis , hypertrophy turbinate , major septum deviation , nasal polyposis recurrent sinusitis Previous nasal sinus surgery Clinically significant cardiovascular , hepatic , GIT , renal , endocrine , infective , haematological , neurological , dermatological , neoplastic condition , gastrooesophageal reflux , depression , TB Participation therapeutic drug trial prior 30 day . Medical therapy permit contraception . Positive pregnancy test Inability unwillingness use contraception patient female childbearing age . History drug abuse urine test show evidence recreational drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Lipopolysaccharide ( LPS )</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Chemokines</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Gene Expression</keyword>
	<keyword>Nasal Challenge</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Nasal</keyword>
	<keyword>Nasosorption</keyword>
	<keyword>Respiratory</keyword>
</DOC>